The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


TRX TISSUE REGENIX GROUP PLC ORD 0.5P

TISSUE REGENIX  Currency  GBX 



 Page 2 of 2

Previous | 1 | 2 |

Time/Date Code Headline Source Impact
07:00 19-Dec-2013 TRX Tissue Regenix to attend JPMorgan Healthcare Event RNS +3.62% Up
07:00 12-Dec-2013 TRX Tissue Regenix signs US distribution agreements RNS +31.22% Up
07:00 22-Nov-2013 TRX Director Share Purchase RNS +15.51% Up
07:00 29-Oct-2013 TRX Presentation at Proactiveinvestors Forum in Dublin RNS +2.80% Up
16:49 28-Oct-2013 TRX Director Share Purchase RNS +3.03% Up
07:00 21-Oct-2013 TRX Publication of DermaPure UK trial results RNS +2.67% Up
16:41 17-Oct-2013 TRX Holding(s) in Company RNS +4.59% Up
16:41 17-Oct-2013 TRX Holding(s) in Company RNS +4.59% Up
16:41 17-Oct-2013 TRX Holding(s) in Company RNS +4.59% Up
07:00 14-Oct-2013 TRX Tissue Regenix USA successful technology transfer RNS +9.76% Up
07:00 08-Oct-2013 TRX Interim Results for six months ended 31 July 2013 RNS +0.97% Up

 Page 2 of 2

Previous | 1 | 2 |

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released, including the day of the release of the news
y = instrument's latest 7 closing prices before the news was released

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank " - " next to the line indicating the RNS issue.


TISSUE REGENIX share - news analysis

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds